hrs4r
Quiero donar

CLAUDIA MONTAÑES FERRER

Firma
CLAUDIA MONTAÑES-FERRER
Posición
Investigador/a Pre-doctoral – R1
Investigadores/as Pre-doctorales – R1

Projectes

Codi oficial: 2024_GECP_CMF Data inicio:01/12/2024 Data fi: 30/11/2026 Investigador/a principal: CLAUDIA MONTAÑES FERRER Organisme finançador: GRUPO ESPAÑOL DE CANCER DE PULMON

Publicacions

Sabaté-Ortega, J, Teixidor-Vilà, E, Sais, E, Hernandez-Martínez, A, Montañés-Ferrer, C, Coma, N, Polonio-Alcalá, E, Pineda, V, Bosch-Barrera, J

Cardiovascular toxicity induced by immunotherapy in non-small cell lung cancer: a systematic review and meta-analysis of observational studies

Frontiers in oncology, 2025, 15 dx.doi.org/10.3389/fonc.2025.1528950
Sabaté-Ortega, J, Albert-Carrasco, M, Escribano-Ferrer, C, Grau-Manrubia, G, Fina-Planas, C, López-Núnez, C, Teixidor-Vilà, E, Bujons-Buscarons, E, Montañés-Ferrer, C, Sala-González, N

Case report: Uncommon gastric metastasis as a presentation of recurrent clear cell renal cell carcinoma

Frontiers in oncology, 2024, 14, 1354127-1354127 dx.doi.org/10.3389/fonc.2024.1354127
Sais, E, PLUJA CASTELLANO, ANNA, MONTAÑES FERRER, CLAUDIA, Bujons-Buscarons, E, PINEDA RIVERO, FRANCISCO JAVIER, Iguaran A, Roselló À, Hernández Martínez A, Teixidor-Vilà, E, ROMERA, ALVARO, Bosch-Barrera, J, ERASO URIÉN, ARANTXA, Oliva-Poch E

1062P Effect of the immunological circadian rhythm on the treatment of locally advanced non-small cell lung cancer treated with consolidation immunotherapy

ANNALS OF ONCOLOGY, 2024, 35, 1-1 dx.doi.org/10.1016/j.annonc.2024.08.1120

Formulari de contacte

Conoce el IDIBGI!

menu